BrightSpring Health Services, Inc. Common Stock (BTSG)vsNovartis AG ADR (NVS)
BTSG
BrightSpring Health Services, Inc. Common Stock
$48.15
+1.39%
HEALTHCARE · Cap: $9.30B
NVS
Novartis AG ADR
$142.94
-1.76%
HEALTHCARE · Cap: $280.79B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 339% more annual revenue ($56.67B vs $12.91B). NVS leads profitability with a 24.7% profit margin vs 1.5%. NVS trades at a lower P/E of 20.3x. BTSG earns a higher WallStSmart Score of 54/100 (C-).
BTSG
Buy54
out of 100
Grade: C-
NVS
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+86.0%
Fair Value
$286.73
Current Price
$48.15
$238.58 discount
Margin of Safety
-52.2%
Fair Value
$109.78
Current Price
$142.94
$33.16 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 338.3% YoY
Revenue surging 29.3% year-over-year
Mega-cap, among the largest globally
Every $100 of equity generates 31 in profit
Keeps 25 of every $100 in revenue as profit
Strong operational efficiency at 27.8%
Generating 1.6B in free cash flow
Areas to Watch
ROE of 5.9% — below average capital efficiency
1.5% margin — thin
Operating margin of 3.0%
Elevated debt levels
2.2% revenue growth
Grey zone — moderate risk
Expensive relative to growth rate
Earnings declined 11.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : BTSG
The strongest argument for BTSG centers on EPS Growth, Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 24.7% and operating margin at 27.8%.
Bear Case : BTSG
The primary concerns for BTSG are Return on Equity, Profit Margin, Operating Margin. A P/E of 100.3x leaves little room for execution misses. Thin 1.5% margins leave little buffer for downturns.
Bear Case : NVS
The primary concerns for NVS are Revenue Growth, Altman Z-Score, PEG Ratio.
Key Dynamics to Monitor
BTSG profiles as a growth stock while NVS is a value play — different risk/reward profiles.
BTSG carries more volatility with a beta of 2.05 — expect wider price swings.
BTSG is growing revenue faster at 29.3% — sustainability is the question.
NVS generates stronger free cash flow (1.6B), providing more financial flexibility.
Bottom Line
BTSG scores higher overall (54/100 vs 51/100) and 29.3% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BrightSpring Health Services, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
BrightSpring Health Services, Inc. (BTSG) is a prominent provider of home and community-based health services, dedicated to addressing the complex needs of a varied patient population, including those with intellectual and developmental disabilities and individuals requiring rehabilitation. The company focuses on delivering personalized care solutions facilitated by a skilled workforce, which enhances patient outcomes and quality of life. With its strategic investments in innovative technology and a firm commitment to quality, BrightSpring is well-equipped to excel in the expanding value-based care market and to effectively navigate the evolving healthcare landscape.
Visit Website →Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?